MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$80,470K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prescription reimbursement liabi...
Accounts receivable
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Prescription reimbursement asset...
Capitalized software
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
8,536
1,169
5,425
1,119
Depreciation and amortization
22,269
21,792
23,146
21,431
Loss on extinguishment of debt
-
-
0
0
Amortization of debt issuance costs and discounts
470
462
454
445
Non-cash operating lease expense
985
925
944
998
Stock-based compensation expense
16,593
16,509
17,919
18,118
Deferred income taxes
5,707
4,069
11,982
8,089
Loss on operating lease asset
0
0
0
0
Loss on disposal of capitalized software
-
-
0
-
Loss on minority equity interest investment
-
-
0
-
Other
271
798
1,334
20
Accounts receivable
-50,581
-3,025
30,212
14,711
Prescription reimbursement assets
322,482
655,199
75,387
-
Prepaid expenses and other assets
-752
-2,177
-14,846
7,437
Accounts payable
-4,926
-4,945
-10,522
3,539
Prescription reimbursement liabilities
289,017
620,839
114,341
-
Accrued expenses and other current liabilities
14,319
1,744
-41,023
45,443
Operating lease liabilities
-1,434
-1,478
-1,537
-1,545
Other liabilities
174
-49
1,178
514
Net cash provided by operating activities
80,832
11,838
32,888
76,023
Purchase of property and equipment
362
1,136
1,241
1,748
Acquisition
0
0
13,440
0
Capitalized software
14,047
20,508
14,589
16,251
Other
-
-
2,500
-
Net cash used in investing activities
-14,409
-21,644
-31,770
-17,999
Proceeds from long-term debt
-
-
0
0
Payments on long-term debt
1,250
1,250
1,250
1,250
Payments of debt issuance costs
-
-
0
0
Repurchases of class a common stock
1,953
12,567
9,430
61,054
Proceeds from exercise of stock options
0
95
0
58
Employee taxes paid related to net share settlement of equity awards
3,186
2,582
2,595
3,567
Proceeds from employee stock purchase plan
369
-
448
0
Net cash used in financing activities
-6,020
-16,304
-12,827
-65,813
Net change in cash and cash equivalents
60,403
-26,110
-11,709
-7,789
Beginning of period
235,710
261,820
273,529
448,346
End of period
296,113
235,710
261,820
273,529
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Prescription reimbursement
liabilities
$289,017K
Accounts receivable
-$50,581K
(-217.38%↓ Y/Y)
Depreciation and
amortization
$22,269K
(-45.21%↓ Y/Y)
Stock-based compensation
expense
$16,593K
(-59.12%↓ Y/Y)
Accrued expenses and
other current...
$14,319K
(542.63%↑ Y/Y)
Net income
$8,536K
(-64.28%↓ Y/Y)
Deferred income taxes
$5,707K
Non-cash operating lease
expense
$985K
(-52.30%↓ Y/Y)
Prepaid expenses and
other assets
-$752K
(-104.76%↓ Y/Y)
Amortization of debt issuance
costs and discounts
$470K
(-45.91%↓ Y/Y)
Other
$271K
(-40.57%↓ Y/Y)
Other liabilities
$174K
(-40.82%↓ Y/Y)
Net cash provided by
operating activities
$80,832K
(37.02%↑ Y/Y)
Canceled cashflow
$328,842K
Net change in cash
and cash...
$60,403K
(136.16%↑ Y/Y)
Canceled cashflow
$20,429K
Prescription reimbursement
assets
$322,482K
Accounts payable
-$4,926K
(-144.43%↓ Y/Y)
Operating lease
liabilities
-$1,434K
(55.00%↑ Y/Y)
Proceeds from employee
stock purchase plan
$369K
(-57.09%↓ Y/Y)
Net cash used in
investing activities
-$14,409K
(79.47%↑ Y/Y)
Net cash used in
financing activities
-$6,020K
(96.14%↑ Y/Y)
Canceled cashflow
$369K
Capitalized software
$14,047K
(-64.58%↓ Y/Y)
Purchase of property and
equipment
$362K
(-31.95%↓ Y/Y)
Employee taxes paid
related to net share...
$3,186K
(-61.64%↓ Y/Y)
Repurchases of class a common
stock
$1,953K
(-98.66%↓ Y/Y)
Payments on long-term
debt
$1,250K
(-50.00%↓ Y/Y)
Buy us a coffee
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)